Graphical Abstract Highlights d Homozygous UBQLN4 germline mutations lead to a genome instability syndrome d UBQLN4 removes ubiquitylated MRE11 from damaged chromatin to curtail DSB resection d UBQLN4 overexpression represses HRR and promotes the use of NHEJ for DSB repair d UBQLN4 overexpression in tumors promotes PARP1 inhibitor sensitivity SUMMARY Genomic instability can be a hallmark of both human genetic disease and cancer. We identify a deleterious UBQLN4 mutation in families with an autosomal recessive syndrome reminiscent of genome instability disorders. UBQLN4 deficiency leads to increased sensitivity to genotoxic stress and delayed DNA double-strand break (DSB) repair. The proteasomal shuttle factor UBQLN4 is phosphorylated by ATM and interacts with ubiquitylated MRE11 to mediate early steps of homologous recombination-mediated DSB repair (HRR). Loss of UBQLN4 leads to chromatin retention of MRE11, promoting non-physiological HRR activity in vitro and in vivo. Conversely, UBQLN4 overexpression represses HRR and favors non-homologous end joining. Moreover, we find UBQLN4 overexpressed in aggressive tumors. In line with an HRR defect in these tumors, UBQLN4 overexpression is associated with PARP1 inhibitor sensitivity. UBQLN4 therefore curtails HRR activity through removal of MRE11 from damaged chromatin and thus offers a therapeutic window for PARP1 inhibitor treatment in UBQLN4overexpressing tumors.
In Brief
Control of MRE11 association with chromatin by UBQLN4 during doublestrand break repair influences repair pathway choice and can be dysregulated in tumorigenesis. 
INTRODUCTION
In response to genotoxic stress, cells activate a signaling network, collectively referred to as the DNA damage response (DDR). The DDR activates cell-cycle checkpoints, DNA repair pathways, and, if damage is beyond repair capacity, triggers cell-death pathways (Reinhardt and Yaffe, 2013) . Following DNA double-strand breaks (DSBs), the DDR is primarily activated by the proximal kinase ataxia telangiectasia mutated (ATM), which phosphorylates a plethora of substrates, such as KAP-1, CHK2, p53, MRE11, RAD50, NBS1, and others (Shiloh and Ziv, 2013) .
The main DSB repair pathways are the canonical nonhomologous end joining (c-NHEJ) pathway and homologous recombination repair (HRR). Error-prone c-NHEJ operates throughout the cell cycle and directly ligates the processed DSB ends, whereas error-free HRR is restricted to late S and G 2 , when a repair template is available (Dietlein et al., 2014) . Additional mutagenic DSB repair pathways are alternative NHEJ and single-strand annealing (Dietlein et al., 2014) . The balance between these different pathways is essential for correct DSB repair (Dietlein et al., 2014) .
In contrast to the wealth of phosphorylation targets in the DDR, the number of known ubiquitylation substrates at DSB sites is small (Harding and Greenberg, 2016) . While K63-linked ubiquitylation mediates functional alterations of the target protein, K48linked ubiquitin chains mark target proteins for proteasomemediated degradation (Walczak et al., 2012) . Notably, we previously observed recruitment of proteasomes to DSB sites (Levy-Barda et al., 2011) , raising the possibility that the regulated turnover of proteins at DSB sites may be critical for a proper DSB response.
In proteasome-mediated protein degradation, ubiquitylated proteins are recognized by specific proteasome subunits (Grice and Nathan, 2016) . Additional selectivity is provided by loosely associated shuttle factors that mediate target recognition by the proteasome. Three such shuttles were identified in budding yeast: Dsk2, Rad23, and Ddi1 (Hartmann-Petersen et al., 2003) . Rad23 and Ddi1 have been implicated in the DDR, as Rad23 functions in nucleotide excision repair (Ng et al., 2003) , and Ddi1 is required in the proteasomal degradation of homothallic switching (HO) endonuclease, which generates a site-specific DSB at the mating type locus (Kaplun et al., 2005) . The mammalian orthologs of Dsk2 are members of the ubiquilin family, ubiquilin1-4 (UBQLN1-4) (Hu et al., 2012) . Ubiquilins contain ubiquitin-like (UBL) and ubiquitin-binding (UBA) domains. Their role as shuttles that direct cargo to the proteasome is mediated by the binding of ubiquitylated proteins through their UBA domain and simultaneous interaction with the proteasome subunit s5a through their UBL domain (Ko et al., 2004) .
Here, we identify a homozygous UBQLN4 germline mutation, p.R326X, in a complex inherited disorder. Affected patients display characteristics similar to other genome instability syndromes, such as ataxia-telangiectasia and others (Hoeijmakers, 2001) . Mechanistically, we show that UBQLN4 is phosphorylated in an ATM-dependent manner and recruited to sites of DNA damage, where it redirects DSB repair toward NHEJ by functionally repressing HRR. We further show that UBQLN4 interacts with ubiquitylated MRE11, to facilitate its proteasomal degradation. Moreover, reduced HRR usage in UBQLN4-overexpressing tumor cells is associated with an actionable PARP1 inhibitor sensitivity.
RESULTS

Identification of the UBQLN4 Deficiency Syndrome
We identified an autosomal recessive syndrome in two consanguineous families (Figures 1A and 1B) . Two patients were followed from birth to 10 and 11 years of age, respectively. Patient A-IV-3 was a stillbirth and was hence not followed further. These patients displayed intellectual impair-ment, growth retardation, microcephaly, facial dysmorphism, hearing loss, ataxia, and anemia. Moreover, a pregnancy in family A was terminated at the end of the first trimester due to polyhydramnios, nuchal translucency, and single umbilical artery (fetus A-IV-5). A detailed clinical description of the patients is provided in Figures 1A, 1B , and S2 and Table S1 and the Human subjects section within the STAR Methods. We performed whole-exome sequencing of cells isolated from A-IV-4 and A-IV-5. This analysis revealed a detrimental homozygous c.976C > T mutation in exon 6 of the UBQLN4 gene in both patients ( Figure S1A ; Table S2 ). This mutation is predicted to create a premature stop codon (p.R326X) ( Figure 1C ). Sanger sequencing confirmed c.976C > T homozygosity in the affected individuals, while the parents were heterozygous carriers (Figures 1C and S1B) . Of note, out of a total of 8 shared homozygous variants, the UBQLN4 c.976C > T mutation was the only shared aberration predicted to be truncating ( Figure S1A ; Table S2 ).
To investigate whether the c.976C > T mutation affects UBQLN4 expression, we performed immunoblots. We analyzed dermal fibroblasts (DMFs) derived from B-IV-3, A-IV-5, and B-III-2 using antibodies directed against C-and N-terminal UBQLN4 epitopes. Neither of these antibodies detected fulllength UBQLN4 in cells from B-IV-3 or A-IV-5, while DMFs derived from B-III-2 showed reduced UBQLN4 expression, compared to wild-type (WT) ( Figures 1D and S1C ). We note that the N-terminal antibody detected a faint unspecific band in WT cells below the full-length UBQLN4 band that was also seen in patient-derived cells ( Figure S1C ). To rule out the possibility of a transcript variant that skips the c.976C > T mutation in exon 6, we performed RNA sequencing (RNA-seq). The expressed allelic fraction of the p.R326X mutation was 100% in both patients ( Figure 1E ). In addition, A-IV-5 and B-IV-3 showed a low-level expression of a novel transcript containing an exon 5-7 splice junction, omitting exon 6 ( Figure 1E ). However, exon 6 skipping leads to a frameshifted transcript, predicted to contain a downstream stop codon (p.L321X), potentially giving rise to a 321-amino-acid protein, which was not detected in patient cells ( Figure 1D ). Of note, patient cells, and to a lesser extent parent cells, showed on average an almost 3-fold decrease in UBQLN4 mRNA expression, compared to WT samples of the same cell type ( Figure S1D) , indicating that the mutant transcripts may be subject to nonsense-mediated mRNA decay. Our data indicate that the c.976C > T mutation creates a UBQLN4-null allele, leading to a novel autosomal recessive syndrome in homozygotes, which we term ''UBQLN4 deficiency syndrome.''
Loss of UBQLN4 Confers Hypersensitivity to Genotoxic Agents
We recently conducted an RNAi screen in conjunction with automated microscopy, using ATM-dependent KAP-1 phosphorylation as a readout ( Figure S1E ) (Baranes-Bachar et al., 2018) . Re-analysis of these experiments revealed sustained KAP-1 phosphorylation in UBQLN4-depleted cells after treatment with the radiomimetic drug neocarzinostatin (NCS), suggesting delayed DNA repair in the absence of UBQLN4 (Figure S1F) . Thus, we next examined the response of cells derived from patient B-IV-3 to genotoxic stress. Patient and WT DMFs were treated with NCS, etoposide, cisplatin, or hydroxyurea (HU). Consistent with a role of UBQLN4 in the DDR, UBQLN4 mutant cells exhibited a significantly increased sensitivity to all four genotoxic agents, compared to WT (Figures  2A-2D ). Heterozygous cells showed NCS, etoposide, and HU sensitivities, between those of patient and WT cells (Figures 2A, 2B, and 2D) . Cisplatin sensitivity was similar in the patient and heterozygous cells ( Figure 2C ). Complementation of patient cells with UBQLN4 wt reverted the hypersensitivity to all four genotoxic agents ( Figures S3A-S3E ). Furthermore, RNAi-mediated UBQLN4 depletion rendered U2OS cells significantly more sensitive against NCS, compared to controls in clonogenic survival assays (Figures S3F and S3G) . Of note, ATM inhibition with KU60019 had a slightly more pronounced effect on NCS sensitization than UBQLN4 depletion ( Figures S3F and S3G ). Next, we quantified DNA damage-induced apoptosis in U2OS cells expressing either two distinct UBQLN4-depleting short hairpin RNAs (shRNAs), or a control hairpin ( Figure S3F ). When cells were treated with NCS, etoposide, cisplatin, or HU, UBQLN4depleted cells displayed a significantly increased cleaved-caspase-3 (CC3)-positive population in response to all four genotoxic agents, compared to controls (Figures 2E-2H ). These results suggest that loss of UBQLN4 confers hypersensitivity to DNA-damaging agents and leads to enhanced apoptotic cell death in response to DNA damage.
UBQLN4 Depletion Results in Impaired DSB Repair
To ask whether UBQLN4 loss of function affects DNA repair kinetics, we next assessed the accumulation and clearance of DNA lesions in DMFs following NCS, etoposide, cisplatin, or HU exposure. We employed automated immunofluorescence microscopy to quantify nuclear gH2AX foci, as a surrogate for unrepaired DNA lesions ( Figures 2I-2M ). In response to NCS and etoposide, we observed a significantly delayed clearance of gH2AX foci in patient and heterozygous cells, compared to WT (Figures 2J and 2K) . Of note, UBQLN4 depletion in U2OS cells resulted in a similarly delayed clearance of NCS-induced gH2AX foci, compared to controls ( Figure S3H ). In contrast to the etoposide and NCS response, cells treated with cisplatin and HU showed a continuous increase of gH2AX foci throughout the 48-hr observation period ( Figures 2L-2M ). In line with defective DNA repair in UBQLN4-deficient settings, patient and heterozygous cells displayed a significantly increased number of gH2AX foci following cisplatin and HU exposure, compared to WT ( Figures 2L-2M ). We observed a massive accumulation of gH2AX foci in late S-phase, specifically in cisplatin-treated UBQLN4 mutant cells, compared to WT ( Figure S3I ). Moreover, the decrease in cell counts induced by each of the genotoxic agents was significantly enhanced in patient cells, and to a lesser extent in heterozygous cells, compared to WT ( Figure S3J ). In line with the experiments shown in Figure S3B , re-expression of ectopic UBQLN4 rescued the number of surviving UBQLN4 mutant cells after NCS treatment ( Figure S3K ).
To determine the impact of UBQLN4 depletion on the sealing of NCS-induced DSBs, we performed neutral comet assays in U2OS cells expressing two distinct UBQLN4-targeting shRNAs or a control shRNA. Of note, alkaline comet assays do not differentiate between single-strand break and DSB, whereas the neutral comet assay specifically reports DSBs (Olive and Baná th, 2006) . The comet assays revealed a substantial DSB repair defect in UBQLN4-depleted cells, which could be rescued upon re-expression of shRNA-resistant UBQLN4 wt ( Figures 2N and S3L-S3M ).
UBQLN4 Is Recruited to Sites of DNA Damage
To ask whether UBQLN4 relocates to sites of DNA lesions, we induced focal DNA damage by micro-laser irradiation of single nuclei in U2OS cells. Using an UBQLN4-specific antibody (Figures S3N and S3O) , we noticed that UBQLN4 was recruited to these sites, where it co-localized with 53BP1 ( Figure 3A) . To further characterize the kinetics of this UBQLN4 recruitment, we expressed ectopic GFP.UBQLN4 in U2OS cells and monitored its recruitment to laser-induced damage. A fraction of GFP.UBQLN4 was recruited to the damage sites within 5 min of damage induction ( Figure 3B ). We also employed biochemical fractionation to demonstrate enrichment of UBQLN4 in the chromatin fraction after NCS exposure ( Figure S4A ). To assess whether the UBL or UBA domains of UBQLN4 were required for this recruitment, we generated UBQLN4 deletion mutants ( Figure S4B ) and found that neither the UBL nor the UBA domain was required for recruitment to sites of laser-induced damage ( Figure S4C ).
ATM-Dependent UBQLN4 Phosphorylation Is Required for a Proper Cellular DDR
A phosphoproteomic screen previously detected a peptide that represented phosphorylation of UBQLN4 on S318 in response to ionizing radiation (IR) (Matsuoka et al., 2007) . Importantly, S318 is located in a highly conserved S-S-Q-P amino acid sequence that contains the potential ATM substrate motif, S 318 -Q (Reinhardt and Yaffe, 2013) ( Figure 3C ). We therefore aimed to validate this finding and to further characterize the regulation and functional significance of this phosphorylation. We raised a polyclonal, phospho-specific antibody against pS318/UBQLN4 and assessed its specificity in anti-GFP immunoprecipitates from IR-treated U2OS cells overexpressing GFP.UBQLN4 or a non-phosphorylatable GFP.UBQLN4 S318A mutant. The anti-pS318 UBQLN4 signal was enhanced following IR in UBQLN4 wt , compared to GFP.UBQLN4 S318A precipitates (Figures S4D and S4E) . When we inspected the anti-GFP precipitates on SDS-PAGE, we also detected endogenous UBQLN4, indicating the formation of homo-dimers or -polymers, an observation that we confirmed in co-immunoprecipitation experiments (Figures S4D and S4F) . The signal obtained with the anti-pS318 antibody in immunoblotting of lysates from irradiated cells was reduced when the cells were UBQLN4 depleted ( Figure S4G ). Notably, pS318/UBQLN4 was induced by several genotoxic agents, including IR, etoposide, camptothecin, and HU (Figures S4H and S4I) . Moreover, pS318/UBQLN4 was detected primarily in the nuclear and particularly the chromatin fraction, whereas only faint signals were obtained in cytoplasmic and membrane fractions ( Figure S4J ). Longitudinal monitoring revealed that pS318/UBQLN4 peaked within 30 min after IR and subsided 4-6 hr later ( Figure 3D ). These kinetics are similar to that of ATM-mediated KAP-1 phosphorylation ( Figure 3D as ataxia telangiectasia-and Rad3-related (ATR) and DNA dependent protein kinase (DNA-PK) (Reinhardt and Yaffe, 2013) , we employed small-molecule inhibitors to examine their role in this phosphorylation. Consistent with an ATM dominance in mediating S318/UBQLN4 phosphorylation, the ATM inhibitor, KU60019, abolished NCS-induced pS318/UBQLN4. The ATR inhibitor, AZ20, appeared to delay this phosphorylation, whereas the DNA-PK inhibitor, KU60648, had no apparent effect on S318 phosphorylation ( Figures 3E and S4K ). We validated the ATM dependence of the S318 phosphorylation in a phosphomass spectrometry experiment ( Figure 3F ; Table S3 ). We treated FLAG.UBQLN4-expressing U2OS cells with NCS (1 hr, 500 ng/mL) or vehicle. To assess the role of ATM in UBQLN4 phosphorylation, we also included cells that were treated with KU60019 30 min prior to addition of NCS. We found 1,400 NCS-induced phosphorylation sites, of which 522 were less abundant in the presence of KU60019 (Table S3 ). Importantly, NCS treatment induced S318 phosphorylation, which was almost completely abolished in the presence of KU60019 (Figure 3F) . Of note, the pS144/UBQLN4 site displayed a similar ATM-dependent and NCS-induced phosphorylation pattern ( Figure S4L ), indicating that UBQLN4 is also targeted by kinase(s), selecting proline-directed motifs.
To ask whether UBQLN4 phosphorylation impacts on sensitivity to genotoxic stress, we used clonogenic survival assays in U2OS cells ( Figures 3G and S4M ). UBQLN4 depletion resulted in marked NCS sensitivity, compared to control cells ( Figure 3G ). This phenotype could be fully rescued by ectopic expression of UBQLN4 wt , whereas UBQLN4 S318A failed to rescue the UBQLN4 depletion phenotype, similar to UBQLN4 mutant proteins lacking either the UBL or UBA domain ( Figures 3G, S4N , and S4O). We next tested whether UBQLN4 phosphorylation interferes with the sealing of NCS-induced DSBs, using a neutral comet assay carried out in the cell clones used in Figure 3G , as well as a UBQLN4-depleted clone that was complemented with a phospho-mimicking S318D mutant ( Figure S4P ). Here, UBQLN4 depletion significantly delayed DSB sealing, compared to cells expressing control shRNA or UBQLN4-depleted cells that were complemented with either WT or UBQLN4 S318D (Figures 3H and S4Q) . UBQLN4-depleted cells complemented with UBQLN4 S318A displayed a comet tail moment that was indistinguishable from that observed in UBQLN4-depleted cells (Figures 3H and S4Q) . These results suggest that UBQLN4 phosphorylation on S318 is functionally important for its role in the DSB response.
Loss of UBQLN4 Leads to Increased HRR Mammalian cells employ two major DSB repair pathways, namely, NHEJ and HRR (Dietlein et al., 2014) . Particularly HRR is dependent on ATM activity (Dietlein et al., 2014) . Here, we showed that UBQLN4 is an ATM substrate and that DSB sealing is markedly impaired in UBQLN4-depleted cells. HRR depends on a 5 0 -3 0 DSB end resection, which is initiated by the MRE11 nuclease (Symington and Gautier, 2011) . As UBQLN4 is a proteasome shuttling factor (Ko et al., 2004) , we next pursued a candidate approach to ask whether UBQLN4 interacts with HRR proteins. We treated GFP-and GFP.UBQLN4expressing U2OS cells with vehicle solution or NCS and performed anti-GFP pull-downs, which revealed that MRE11 co-precipitated with GFP.UBQLN4, particularly after NCS exposure ( Figure S5A ). These data suggest that MRE11 is one of probably many UBQLN4 interaction partners. Based on this observation, we hypothesized that UBQLN4 might direct DSB repair pathway choice. Thus, we used two distinct assays to assess the differential use of HRR and NHEJ in UBQLN4depleted and UBQLN4-overexpressing U2OS cells. Using the SeeSaw reporter system (Ló pez-Saavedra et al., 2016) to quantify the relative use of HRR and NHEJ, we found that UBQLN4 depletion significantly increased the relative contribution of HRR over NHEJ in DSB repair, whereas UBQLN4 overexpression significantly increased the relative use of NHEJ (Figures 4A and S5B) . Of note, expression of UBQLN4 S318A failed to promote NHEJ ( Figure 4A ).
We corroborated these data using the DR-GFP reporter (López-Saavedra et al., 2016) ( Figure S5C ). Similar to the SeeSaw system, the DR-GFP assay demonstrated significantly increased HRR usage in UBQLN4-depleted cells, compared to controls ( Figure 4B ). UBQLN4-overexpressing cells showed significantly decreased HRR usage, whereas expression of UBQLN4 S318A had no detectable impact on HRR usage ( Figure 4B ). (D) Immunoblot displaying the time course of the S318 UBQLN4 phosphorylation in U2OS cells after 10 Gy IR. (E) UBQLN4 phosphorylation is ATM mediated. U2OS cells were treated with the indicated inhibitors 30 min prior to NCS (500 ng/mL, 1 hr) exposure and subsequent immunoblotting. Arrows indicate pS318/UBQLN4 bands. ATMi, KU60019 (5 mM); DNA-PKi, KU60648 (10 mM); ATRi, AZ20 (0.5 mM). Figure S4 and Table S3 . We validated these findings in vivo, by assessing the role of C. elegans ubql-1, the nematode ortholog of UBQLN4, in HRR. During the first hours of embryogenesis, C. elegans selectively employs HRR to repair DSBs (Lemmens and Tijsterman, 2011) . IR of early WT C. elegans embryos led to a dose-dependent survival reduction, which was significantly alleviated in the ubql-1 mutant ( Figure 4C ). These data imply an evolutionarily conserved role for UBQLN4 in DSB repair.
Our data may suggest a model in which UBQLN4 regulates DSB repair pathway choice by repressing HRR through removal of HRR factors from the damaged site. We tested this model by comparing the NCS-induced spatial dynamics of several HRR factors in UBQLN4 mutant and WT cells. We longitudinally monitored RPA70 and RAD51 foci (indicators of ongoing HRR), as well as 53BP1 foci (indicating NHEJ activity) (Dietlein et al., 2014) and observed a significantly increased number of RPA70 and RAD51 foci in patient cells, compared to WT (Figures 4D and 4E) . This difference was particularly obvious in S-phase and G 2 /M cells ( Figures 4D and 4E ). In contrast, 53BP1 foci were significantly reduced in NCS-treated patient cells, compared to controls ( Figure 4F ), supporting a role of UBQLN4 in curtailing HRR. To rule out a net effect of the different amounts of DNA lesions in the different genotypes ( Figure 2J ), we normalized the number of RPA70 and 53BP1 foci against amounts of gH2AX foci (representing unrepaired DSBs) ( Figures S5D and  S5E ). The results indicated that the increased RPA70 and decreased 53BP1 foci in UBQLN4 mutant cells were not the result of an increased number of unrepaired DNA lesions per se ( Figures S5D and S5E ).
UBQLN4 Is Required for MRE11 Turnover in the Chromatin
We showed that the DSB resection-initiating nuclease MRE11 interacts with UBQLN4 in response to NCS ( Figure S5A ). To scrutinize the role of the UBQLN4:MRE11 interaction for DSB repair, we examined the effect of UBQLN4 depletion on MRE11 retention in the damaged chromatin (Figures S5F and S5G) . We carried out cycloheximide chase experiments in conjunction with NCS treatment in WT and UBQLN4 mutant cells. These experiments revealed a significantly increased accumulation of MRE11 in the chromatin fraction of UBQLN4 mutant cells, compared to WT, 6 hr after NCS treatment ( Figures  S5F and S5G ). This observation was validated using longitudinal immunofluorescence. As shown in Figures 4G and 4H , MRE11 nuclear foci were significantly increased in UBQLN4 mutant DMFs 6-48 hr after NCS treatment, compared to WT and UBQLN4 wt -complemented patient cells. Of note, the cell-cycle distribution of untreated and NCS-exposed WT, UBQLN4 mutant, and UBQLN4 wt -complemented patient cells showed only mild differences ( Figure S5H ). Specifically, WT cells showed slightly increased S-phase and G 2 populations, compared to UBQLN4 mutant cells ( Figure S5H ), which, if anything, should lead to an underestimation of the increased HRR in UBQLN4 mutant cells.
To ask whether UBQLN4-deficient cells accumulate ubiquitylated proteins at DNA damage sites, we performed immunofluorescence with the FK2 antibody, to detect mono-and polyubiquitylated proteins. UBQLN4 mutant cells showed increased numbers of FK2-positive nuclear foci after NCS exposure, compared to WT or patient cells complemented with UBQLN4 wt (Figures 4G and 4I ). Pre-treatment with the proteasome inhibitor MG132 led to similar amounts of NCSinduced FK2 foci in patient and WT cells ( Figure S5I ), indicating that the NCS-induced FK2 foci in patient cells result primarily from inefficient proteasomal clearance of ubiquitylated proteins from damage sites. Intriguingly, the overlap area of MRE11 and FK2 foci was markedly increased in patient cells, compared to WT and UBQLN4-complemented patient cells, potentially indicating that MRE11 is ubiquitylated itself and accumulates at DSB sites in patient cells (Figures 4G and 4J) . We obtained similar data in ubql-1 mutant C. elegans. IR treatment induced massive accumulation of FK2 foci after 24 hr in the distal germline of ubql-1 mutant worms, compared to WT animals (Figures 4K and 4L) . (B) Cells harboring a single copy of DR-GFP were transfected with the indicated siRNAs or FLAG plasmids and gene conversion was assessed. Non-target siRNA and FLAG plasmid served as controls. siRNA against CTIP was used as a positive control. The data represent 4 sets of triplicate experiments. Error bars represent SEM. A paired t test was used for statistical analysis. *p < 0.05, **p < 0.01, ***p < 0.001. (C) C. elegans ubql-1(tm1574) mutants display improved embryonic survival upon IR (40 Gy), compared to N2 WT, indicative of an elevated HRR repair capacity. The brc-1 mutant strain served as an HRR-defective control. brc-1(tm1145) embryos showed increased lethality after IR. The data represent 3 replicate experiments. Error bars represent SD of the mean. A paired t test was used for statistical analysis. *p < 0.05. (D-F) RPA70-(D), RAD51-(E), and 53BP1 nuclear foci (F) were quantified according to cell-cycle stage. Experiments were analyzed with R, using ordinary twoway ANOVA. Bonferroni post hoc analysis was applied to determine p values of selected pairs defined in a contrast matrix using the R library multcomp. Error bars represent the SD of the mean of 3 replicate wells analyzed in one experiment. Each experiment was carried out twice. Two-way ANOVA with Bonferroni post hoc test, *p < 0.05. (G) Representative images of MRE11-and ubiquitin (Ub) nuclear foci, using quantitative HCS microscopy for untreated and NCS-treated (500 ng/mL) DMFs. DAPI served as a counterstain. Overlay images were generated between MRE11 and Ub stainings for indicated genotypes. Scale bar, 10 mm. (H and I) Cells of the indicated genotypes were treated with NCS (500 ng/mL) and stained for nuclear MRE11-(H) and ubiquitin (Ub) foci (I) at the indicated time points. 2,500 cells/well were counted at each time point, and Ub fluorescence was quantified, as in (D)- (F) . n = 3 replicate experiments with 2 replicate wells each, mean ± SEM, two-way ANOVA with Bonferroni post hoc test, *p < 0.05. (J) The overlap area (in %) of MRE11 and Ub foci was calculated by overlay of nuclear foci data generated in (H) and (I) for the indicated genotypes. n = 3 replicate experiments with 2 replicate wells each, mean ± SEM, two-way ANOVA with Bonferroni post hoc test, *p < 0.05. (K) ubql-1(tm1574) mutants display elevated levels of ubiquitinated proteins in the distal germline upon IR, as shown by increased numbers of FK2 stained foci. Scale bar, 10 mm. (L) For quantification of (K), five germlines per genotype and condition were scored. Error bars represent SD of the mean. A paired t test was used for statistical analysis. *p < 0.05. See also Figure S5 .
To assess whether MRE11 was ubiquitylated after NCS treatment, we expressed HIS.Ubiquitin and either FLAG.MRE11 or empty vector in HEK293FT cells. Anti-HIS immunoprecipitation revealed NCS-induced co-precipitation of FLAG.MRE11, suggesting that MRE11 was ubiquitylated following DNA damage ( Figure S5J ). To ask whether UBQLN4 interacted with MRE11 in a ubiquitylation-dependent fashion, we co-expressed FLAG.MRE11 and GFP.UBQLN4 and immunoprecipitated GFP after NCS exposure. FLAG.MRE11 efficiently co-precipitated with GFP.UBQLN4, but not with a GFP control ( Figure S5K ). Importantly, the FLAG.MRE11:GFP.UBQLN4 interaction was repressed by pre-treatment of the lysates with the deubiquitylating protease USP2 ( Figure S5K ).
To address whether the interaction between MRE11 and UBQLN4 was dependent on the C-terminal ubiquitin-interacting UBA in UBQLN4, we co-expressed FLAG.MRE11 and either GFP.UBQLN4 or GFP.UBQLN4 lacking the UBA domain (GFP.UBQLN4 DUBA ) in HEK293FT cells. While GFP.UBQLN4 efficiently co-precipitated with anti-FLAG immunoprecipitates, UBQLN4 DUBA could not be detected in these precipitates (Figure 5A) . We confirmed these data using endogenous immunoprecipitations from NCS-treated HEK293FT cells ( Figure 5B ). Intriguingly, while FLAG.MRE11 displayed a robust co-precipitation with GFP.UBQLN4 wt , this interaction was massively reduced when we expressed GFP.UBQLN4 S318A , indicating that this interaction was dependent on ATM-mediated S318/ UBQLN4 phosphorylation ( Figure 5C ). Together, our data provide evidence for a model in which, following DSB induction, UBQLN4 interacts with MRE11 in a ubiquitylation-dependent manner, in order to remove MRE11 from the site of genotoxic damage. In line with a proteasome-dependent turnover of nuclear MRE11, we find that NCS-treated UBQLN4 mutant cells display significantly increased nuclear ubiquitin and MRE11 staining, compared to WT ( Figures S5L-S5N ). Importantly, following proteasome inhibition with MG132 for 48 hr, the levels of nuclear ubiquitin and MRE11 staining were similar in UBQLN4-proficient and -deficient cells ( Figures S5M and S5N ), suggesting that UBQLN4 controls the proteasome-dependent nuclear MRE11 turnover.
Fitting with a role of MRE11 in initiating DSB end resection, we showed that UBQLN4 mutant cells, which display aberrant MRE11 retention at sites of DNA damage, show increased numbers of RPA70 and RAD51 nuclear foci, following NCSinduced DNA damage ( Figures 4D, 4E , 4G, and 4H). This observation may reflect an increased number of DSBs that are being resected. To verify that the increased number of RPA70 foci in UBQLN4-deficient cells was due to increased resection initiation, rather than enhanced resection processivity, we used the single-molecule analysis of resection track (SMART) resection assay (Cruz-García et al., 2014) . This assay reports resection processivity at breaks, in which resection has been initiated, without considering the number of breaks. These experiments revealed that neither UBQLN4 depletion, nor overexpression of FLAG.UBQLN4 or FLAG.UBQLN4 S318 affect resection processivity ( Figure 5D ). Our results thus indicate that UBQLN4 depletion leads to increased MRE11-dependent initiation of endresection and subsequent shifting of more DSBs toward HRR.
To verify MRE11 as a functionally relevant UBQLN4 substrate, we next asked whether MRE11 inhibition with exo-(Mirin) and endonuclease (PFM01) inhibitors overcomes the relatively increased HRR activity in UBQLN4-defective cells. Pre-treatment with Mirin and PFM01 led to a significant inhibition of NCS-induced nuclear RAD51 foci in WT and UBQLN4 mutant cells ( Figures 5E and 5F ). In conclusion, our mechanistic data indicate that MRE11 serves a checkpoint function in licensing the HRR process, which is tightly controlled by UBQLN4.
UBQLN4 Overexpression Protects from Genotoxic Stress
Given that UBQLN4 overexpression results in a relative increase of NHEJ over HRR ( Figure 4A ) and an absolute decrease of HRR ( Figure 4B ), we asked whether overall DSB repair capacity may be affected in cells overexpressing UBQLN4. To this end, we assessed DNA repair capacity through immunofluorescence detection of NCS-induced gH2AX foci in U2OS expressing GFP or GFP.UBQLN4. UBQLN4 overexpression resulted in significantly faster clearance of gH2AX foci, starting 12 hr after the initial insult ( Figure 6A ). Moreover, neutral comet assays demonstrated that cells expressing UBQLN4.GFP sealed NCSinduced DSBs significantly more efficiently than control cells ( Figures 6B and 6C ). This effect was particularly obvious 12 hr after NCS application. Furthermore, clonogenic survival assays revealed that UBQLN4 overexpression protected cells from the cytotoxic effect of NCS ( Figure 6D ). Lastly, UBQLN4-overex-pressing cells displayed significantly less CC3 positivity (marker of apoptosis) 24 hr after exposure to high-dose NCS, compared to controls ( Figures 6E and 6F ).
High-Level UBQLN4 Expression Is Associated with an Actionable PARP1 Inhibitor Sensitivity To assess the relevance of UBQLN4 expression in human cancer, we examined 498 neuroblastoma cases (Zhang et al., 2015) . UBQLN4 mRNA expression was significantly increased in stage 3 and 4 neuroblastomas, compared to stage 1 disease ( Figure 6G ). We further found that UBQLN4 mRNA levels were significantly increased in high-risk cases (n = 176), compared to non-high-risk patients (n = 318) ( Figure 6H ). Moreover, highlevel UBQLN4 expression (quartile of patients with high UBQLN4 expression, n = 125) was associated with reduced event-free survival (EFS) and overall survival (OS), compared to patients displaying intermediate, low or very low UBQLN4 expression (n = 117, n = 128, n = 128, respectively) ( Figures S6A and 6I ).
We next assessed UBQLN4 mRNA levels in breast (n = 5,143), lung (n = 2,437), and ovarian cancer (n = 1,816), using publicly available data . Again, high UBQLN4 expression was significantly correlated with reduced OS in these cohorts ( Figures S6B-S6D ). Further study of the TCGA database (Cancer Genome Atlas Network, 2015) revealed that high UBQLN4 expression in melanoma (mRNA Z score R2) also results in inferior disease-free survival (DFS) and OS, compared to patients with normal UBQLN4 expression (mRNA Z score <2 and >À2) ( Figures S6E and S6F) . Moreover, in metastatic melanoma, high UBQLN4 expression correlated with reduced DFS and OS, compared to patients with low UBQLN4 expression ( Figures S6G and S6H) . We further performed immunohistochemistry on melanoma specimens, which were derived from nevus (n = 5), primary melanoma (PRM; n = 8), lymph node metastasized (LNM; n = 10), and distant organ metastasized (DOM; n = 10) samples. UBQLN4 levels were higher in metastasized (DOM, LNM) than in nevus samples ( Figures S6I-S6J ). Thus, our data derived from distinct entities indicate that highlevel UBQLN4 expression is enriched in high-risk and/or advanced tumors and is associated with reduced OS.
Given that HRR deficiency is associated with sensitivity to PARP1 inhibitors (Dietlein et al., 2014) , we profiled olaparib sensitivity in UBQLN4-overexpressing U2OS cells and isogenic controls. UBQLN4 overexpression significantly increased olaparib sensitivity ( Figure S6K ). We further tested the sensitivity of neuroblastoma cell lines expressing high (SY5Y) or low (GIMEN) UBQLN4 levels and found that SY5Y cells displayed significantly enhanced olaparib sensitivity, compared to GIMEN cells ( Figures  S6L and S6M) . To substantiate the role of UBQLN4 in mediating (K) SY5Y cells were transduced with control shRNA or 2 shRNAs against UBQLN4 and treated with olaparib (96 hr). Viability was assessed by CellTiterGlo assays. Error bars represent the SD of the mean of 3 experiments. p values were calculated using the t test with Welch's correction not assuming equal variance. *p < 0.05, **p < 0.01, ***p < 0.001. (L) Neuroblastoma cell lines were treated with olaparib (96 hr) and and viability was assessed by CellTiterGlo assays. IC 50 values were determined in 3 experiments. Cells were grouped in UBQLN4 low (expression below median) or UBQLN4 high (expression above median). p value was calculated using the Mann-Whitney U test. (M) Bar chart of the cells reported in (L) . Cells are sorted according to their relative UBQLN4 expression. In light gray are cells with IC 50 below the median, and in dark gray are cells with IC 50 above the median. See also Figure S6 . olaparib sensitivity, we depleted UBQLN4 in SY5Y cells and overexpressed UBQLN4 in GIMEN cells ( Figures S6N and S6O ). As shown in Figures 6J and 6K , UBQLN4 overexpression in GIMEN cells significantly increased olaparib sensitivity, whereas UBQLN4 depletion in SY5Y cells significantly increased their olaparib resistance. Of note, neither SY5Y nor GIMEN cells are MYCN amplified. To test whether high-level UBQLN4 retains its predictive value in MYCN-amplified cells, we examined olaparib sensitivity in NMB and SKNDZ neuroblastoma cell lines, which display high-and low-level UBQLN4 expression, respectively (Harenza et al., 2017) (Figure S6P ). Increased olaparib sensitivity was preserved in NMB cells, whereas SKNDZ cells were more resistant (Figure S6Q) . We next assessed the olaparib response in a panel of 12 additional neuroblastoma cell lines and found that cells expressing high UBQLN4 levels showed a significantly increased olaparib sensitivity, compared to cells with low expression ( Figures 6L and 6M) . These data indicate that elevated UBQLN4 levels are associated with PARP1 inhibitor sensitivity.
DISCUSSION
The UBQLN4 deficiency syndrome described here is characterized by clinical symptoms frequently detected in genome instability syndromes (Hoeijmakers, 2001) . Here, we demonstrated that UBQLN4 deficiency led to marked cellular sensitivity to genotoxic stress, that UBQLN4 was recruited to sites of DNA damage, and that it was an ATM substrate in the DDR. Importantly, the ATM-mediated phosphorylation was functionally significant for the role of UBQLN4 in the DDR.
Mechanistically, we showed that UBQLN4 impacted on DSB repair pathway choice. It has recently become evident that maintenance of the exquisite balance between these pathways is critical for timely DSB repair and genome maintenance (Baranes-Bachar et al., 2018) . We found that the NHEJ:HRR ratio in UBQLN4-depleted cells was skewed toward HRR, while ectopic UBQLN4 overexpression resulted in a relative increase in NHEJdriven DSB sealing over HRR. These observations were further confirmed in C. elegans, where ubql-1 mutants displayed increased HRR proficiency. Importantly, UBQLN4 overexpression resulted in an absolute decrease in HRR usage. Further mechanistic insight into these effects came from the observation that the apical HRR regulator MRE11 was retained at sites of DSBs in UBQLN4-deficient cells. We further revealed that MRE11 was ubiquitylated following DNA damage and demonstrated that UBQLN4 specifically interacted with ubiquitylated MRE11 in response to DNA damage. Moreover, this interaction depended on the UBA domain of UBQLN4, as well as ATMmediated S318/UBQLN4 phosphorylation. Finally, we showed that excessive RAD51 foci formation following NCS treatment in UBQLN4-deficient cells could be reverted to normal levels, when the endo-or exonuclease activities of MRE11 were pharmacologically inhibited. Based on our data, it is tempting to speculate that a potential function of UBQLN4 within the DDR is to assist in the timely removal of DDR factors, such as MRE11, from damaged chromatin, in order to prevent inappropriate DSB end resection and subsequent HRR. However, we note that our data do not exclude the possibility that UBQLN4 has additional interaction partners within and outside of the DDR. A dose-dependent role for UBQLN4 in promoting the use of NHEJ is supported by the DSB repair reporter assays. The relative increase in NHEJ usage in UBQLN4-overexpressing cells may be driven by the functional repression of HRR through the removal of HRR factors, such as MRE11, from damaged chromatin. Thus, when the UBQLN4 level is altered in either direction, the NHEJ:HRR ratio is markedly affected.
Our data suggest a primarily nuclear role of UBQLN4. However, UBQLN4 does not contain an obvious nuclear localization sequence. In line with this, we also find a fraction of UBQLN4 localized in the cytoplasm (Figures S3N and S4J) . Moreover, UBQLN1, which shares $71% amino acid sequence homology with UBQLN4, is involved in triaging incorrectly targeted membrane proteins in the cytosol to a ubiquitin ligase to promote degradation (Itakura et al., 2016) . Thus, it is conceivable that UBQLN4 is relocated to the nucleus following decoration with a yet unidentified post-translational modification.
We found a correlation between poor OS and elevated UBQLN4 expression in neuroblastoma, melanoma, and ovarian, breast, and lung cancer. Our data indicate that UBQLN4 overexpression may be a selected event in different cancer entities. We provide a rationale for this observation by showing that UBQLN4 overexpression in cultured cells enhances DSB sealing, reduces apoptosis, and increases survival, following NCS treatment. It is conceivable that UBQLN4 overexpression is selected in cancer cells, since it facilitates effective coping with endogenous DSBs, such as those occurring during replicative stress. While this largely NHEJ-mediated, more effective DSB sealing in UBQLN4-overexpressing cells protects them from acute genotoxic stress, it is likely to be highly mutagenic, as NHEJ is an error-prone mechanism (Dietlein et al., 2014) . Thus, NHEJ-driven mutagenesis may also be selected for in cancer cells, since it further promotes genome instability and oncogenic transformation.
Defective HRR in the context of BRCA1 or BRCA2 loss-offunction mutations is associated with PARP1 inhibitor sensitivity (Dietlein et al., 2014) . Consistent with an HRR defect in UBQLN4overexpressing cells, we found that cells with high UBQLN4 expression were significantly more sensitive to olaparib than cells with low UBQLN4 expression. It was recently proposed that NHEJ promotes genomic instability and cytotoxicity in HRR-deficient cells treated with PARP1 inhibitors (Patel et al., 2011) . In extrapolation of these data, the enhanced NHEJ observed in UBQLN4-overexpressing cells may contribute to the toxicity inflicted by PARP1 inhibitors in these cells.
Altogether, our data reveal the biology of a new genome instability syndrome, provide evidence of a role for UBQLN4 in regulating DSB repair pathway choice, and identify UBQLN4 overexpression as a predictor of poor survival in various cancer entities that is associated with an actionable sensitivity to PARP1 inhibitors.
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Human subjects
Written informed consent was obtained from the UBQLN4 deficiency syndrome families for participation in this study. The study was performed according to the Declaration of Helsinki protocols and was approved by the local institutional review board in Essen (ethics vote 12-5089-BO for CRANIRARE). All subjects were not involved in previous procedures.
Patient A-IV-4 -c.f. Figure 1A , Figures S2A-S2M Pregnancy was complicated by nuchal edema and polyhydramnios. Birth occurred at 35 weeks of gestation with a weight of 1960 g (-1.5 SD), a length of 47 cm (À0.3 SD) and occipitofrontal circumference (OFC) of 33 cm (mean). The patient had a respiratory failure that required mechanical ventilation. At birth, he exhibited hypertelorism, microphthalmia, micrognathia, dysplastic and lowset ears with overfolded helices, a right-sided preaxial polydactyly, and bilateral simian creases ( Figures S2B-S2F ). Re-examination at the age of 5 4 / 12 years revealed low body measurements [weight: 11 kg (À5.5 SD), length: 102 cm (À2.5 SD), OFC: 47.5 cm (À3.4 SD)]. He was able to crawl, but not walk without support. Deafness and a cryptorchidism were noted as well as proptosis, downward slanting palpebral fissures, and dysplastic ears ( Figures S2G-S2I ). At 11 years of age all body measurements were low [height: 116 cm (À4.1 SD), weight: 16 kg (À10.9 SD) and OFC: 48 cm (À4.8 SD)]. The facial dysmorphisms remained ( Figures  S2J-S2L ) and dry skin and prominent veins were noted, especially on the forehead and chest. A sleep disorder was reported by the mother, as well as abnormal feeding behavior with constant craving for food, notable in view of the low weight gain. No abnormal reaction to sunlight was reported other than light-sensitive eyes. Blood count showed anemia with a hemoglobin of Continued REAGENT or RESOURCE SOURCE IDENTIFIER 10.5 g/dl (reference: 11.8-14.9 g/dl), MCV of 76.0 fl (reference: 77-95 fl), MCHC of 30.7 g Hb/dl (reference: 31-39 g Hb/dl). Neurological examination revealed spasticity of the lower extremities with brisk reflexes and contractures of both knees. The patient was able to walk independently, presenting insecure circumduction gait pattern. The upper extremities showed slightly increased muscle tone with almost normal function of small hand muscles. Muscle tone of the trunk was reduced. Cranial nerve examination revealed no anomalies apart from esotropia and saccadic eye movements. Speech development was markedly retarded, but he was still able to produce double syllables. The patient presented stereotypic autistic gestures such as body rocking and head nodding, and self-biting and pinching was reported by the mother. Exome sequencing revealed the homozygous mutation chr1:g.156,044, 148G > A [GRCh38/hg38]; c.976C > T (GenBank: NM_020131.4); p.(Arg326Ter) (NP_064516.2) in the UBQLN4 gene.
Patient B-IV-3 -c.f. Figure 1B, Figures S2N-S2W Pregnancy was complicated by nuchal edema and oligohydramnios. Birth occurred at 38 weeks of gestation with: [weight: 1970 g (-3.0 SD), length: 46 cm (À2.2 SD) and OFC: 33.5 cm (-1.0 SD)]. At 7 weeks of age, proptosis, large nose, small mouth and micrognathia were noted. At the age of 1 3 / 12 years low anthropometric measures were observed: [weight: 7500 g (À2.8 SD), length: 75 cm (À1.8 SD), OFC: 46 cm (À1.7 SD)]. The patient was unable to crawl or sit and did not speak. Deafness was diagnosed as well as hypotelorism, brachycephaly, cryptorchidism, hypoplastic nails, and abnormal semicircular canals. At the age of 6 1 / 12 years anthropometric measures were low: [height: 100 cm (À3.8 SD), weight: 15 kg (À3.2 SD) and OFC: 50 cm (À1.7 SD)], and the patient was unable to walk or speak. Proptosis, large nose, short philtrum, camptodactyly of fingers IV/V, contractures of both knees and cryptorchidism were observed ( Figures S2P-S2R ). Recurrent respiratory tract infections reported. At the age of 10 2 / 12 years, body measurements were: [height: 117 cm (À3.7 SD), weight: 16.9 kg (À5.6 SD) and OFC: 50.5 cm (À2.4 SD)]. Facial dysmorphisms did not change, and hirsutism, prominent scalp veins, dry skin and three very dark nevi on the soles were observed ( Figures S2S-S2W) . Sleep disturbances were reported as well as abnormal feeding behavior with constant craving for food. There was no abnormal reaction to sunlight. Microcytic-hypochromic anemia was identified. Neurological examination revealed spasticity of the lower extremities with contractures of the knees. The patient was unable to walk independently. The upper extremities showed slightly increased muscle tone with almost normal function of small hand muscles, and reduced muscle tone of the trunk. Cranial nerve examination revealed difficulties initiating pursuit eye movements but the nerve was otherwise normal. There was no progress in speech development. Stereotypic autistic behavior (repetitive noise making, teeth grinding) was observed. Exome sequencing revealed the homozygous mutation chr1:g.156,044,148G > A [GRCh38/hg38]; c.976C > T (GenBank: NM_020131.4); p.(Arg326Ter) (NP_064516.2) in the UBQLN4 gene.
Patients A-IV-3 and A-IV-5 -c.f. Figure 1A Further clinical information regarding patient A-IV-3 and A-IV-5 can be found in Table S1 .
C. elegans strains and maintenance All worms (age: day 1 of adulthood; sex: hermaphrodites) were grown and maintained at 20 C on nematode growth medium (NGM) agar plates seeded with the E. coli strain OP50 as food source. The Bristol strain N2 was used as wt. Strain DW102 brc-1(tm1145) served as positive control for the HRR assay. The FX1574 ubql-1(tm1574) strain was obtained from the Shared Information of Genetic Resources (SHIGEN; http://shigen.nig.ac.jp/shigen/index.jsp) Center of Genetic Resource Information, National Institute of Genetics, Mishima, Japan, and the presence of the (tm1574) allele was confirmed via genotyping PCR. All strains were backcrossed 4 generations to ancestral N2 and had an uncompromised health status. Worms were not involved in previous procedures and test naive. . Medium for all neuroblastoma cell lines contained 10% fetal bovine serum and cells were grown at 37 C and 5% CO 2 . All commercially available cell lines were not further authenticated. The DNA-PK inhibitor, KU60648, the ATM inhibitor, KU60019, the ATR inhibitor AZ20, the PARP1 inhibitor olaparib and the MRE11 inhibitors Mirin and PFM01 were diluted in DMSO prior to addition to the culture medium. Cells were irradiated using an X-ray instrument (model 160HF, Philips, Germany), or treated with NCS, hydroxyurea, cisplatin, camptothecin or etoposide.
METHOD DETAILS
Whole-exome sequencing Genomic DNA was extracted from peripheral blood using standard methods. For library preparation, 1 mg of DNA was fragmented by adaptive focused acoustics on a Covaris S220 (Covaris Inc, Woburn, MA, USA) for 60 s with a duty cycle of 10%, intensity of 5, and 200 cycles per burst. Library was generated on fragmented DNA using TruSeq Sample Preparation Kit v2 (Illumina) following lowthroughput and gel-free method protocols. . Variants with a frequency in any database of > 1% or present in our inhouse database in more than two distinct phenotypes were excluded. Variants further than 10 bp form the exon/intron boundaries and exonic variants not predicted to affect protein sequence were also excluded. Finally, variants not present in both datasets, heterozygous variants and hemizygous variants were also excluded.
RNA sequencing
Libraries were prepared using the Illumina TruSeq stranded mRNA sample preparation Kit. Starting with 1 mg of total RNA, poly-A selection (using poly-T oligo-attached magnetic beads) followed, and mRNA was purified and fragmented using divalent cations under elevated temperature. RNA fragments underwent reverse transcription using random primers followed by second strand cDNA synthesis using DNA Polymerase I and RNase H. After end repair and A-tailing, indexing adapters were ligated. The products were purified and amplified (14 PCR cycles) to create the final cDNA libraries. After library validation and quantification (Agilent Tape Station), equimolar amounts of the libraries were pooled. The pool was quantified using the Peqlab KAPA Library Quantification Kit and the Applied Biosystems 7900HT Sequence Detection System. The pool was sequenced in an Illumina HiSeq 4000 sequencer with a paired-end (2x75nt) protocol. Raw sequencing reads were mapped to the reference genome (hg19) using the Star aligner, and FPKM expression values were computed based on the refSeq reference transcriptome. Splice junctions between exon 5 and 7 of UBQLN4 were extracted from the alignments (spliced reads) and normalized to the coverage of the corresponding exons. Finally, the relative proportion of the splice junctions of exon 5-6, 6-7, and 5-7 were determined.
Vector constructs
Full-length UBQLN4 cDNA cloned in pCDNA3.1 was received from Vivian Su (University of Hawaii at Maona), PCR amplified, and cloned into pLNCX2 (Clontech, Mountain View, CA) using MluI and NotI restriction sites. FLAG or eGFP were PCR amplified and cloned n-terminal using BglII and MluI restriction sites. GFP.UBQLN4.S318A mutant cDNA was generated by introducing a point mutation (T952G) and GFP.UBQLN4.S318D mutant cDNA was generated by introducing two point mutations (T952G, C953A) utilizing the QuickChange II Site-Directed Mutagenesis Kit (Agilent, CA, USA). The GFP.UBQLN4DUBL construct was obtained by deleting the N-terminal 89 amino acid residues from the protein. The GFP.UBQLN4DUBA construct was obtained by deleting the C-terminal 44 amino acid residues from the protein.
Retroviral and lentiviral vector production
HEK293FT cells were plated into 10 cm dishes in DMEM + 10% FCS, and 24 hr later were co-transfected with pMDLg/pRRE and pMD2.G packaging plasmids and pLNCX2 expression plasmids encoding various UBQLN4 constructs or empty vector using CaCl 2 transfection. Briefly, cells were seeded to a confluency of 50%-70%. 500 ml 250 mM CaCl 2 solution were added into an Eppendorf tube as well as 10 mg of vector. Afterward, 500 ml 2x HEBS buffer were added dropwise while vortexing the solution thoroughly. The solution was then added dropwise onto the cells. The next day, medium was changed to DMEM + 20% FCS. Cell culture supernatants were collected 24, 48 and 72 hr later, centrifuged at 300 g for 5 min and sterile filtered. Using these viral supernatants, HDFs or U2-OS cells were transduced in the presence of 8 mg/ml polybrene for 24 hr and subsequently selected with G418. For RNAimediated gene silencing, replication-incompetent lentiviruses were produced with pLKO.1-Puro based vectors, which expressed specific shRNAs targeting UBQLN4. For that purpose, HEK293FT cells were co-transfected with pRSV-Rev, pMDLg/pRRE and pCMV-VSV-G packaging and envelope plasmids and pLKO.1 expression plasmids. Supernatants were collected after 24, 48 and 72 hr, centrifuged at 300 g for 5 min and sterile filtered. U2-OS cells were transduced with these viral supernatants in the presence 8 mg/ml polybrene for 72 hr (3 cycles of transfection) and selected using puromycin. Finally, knockdown efficiency was confirmed by immunoblotting.
RNA Interference
Cells were grown to 50% confluence and transfected with respective siRNA (UBQLN4, CTIP, Control) using DharmaFECT1 transfection reagent (Dharmacon Inc.). For that purpose, diluted siRNA (tube 1) and DharmaFECT1 transfection reagent (tube 2) were added to separate tubes containing serum-free medium and incubated for 5 min at room temperature. Subsequently, contents of tube 1 were added to tube 2 and incubated for 20 min at room temperature and distributed onto respective cell culture dishes. Cells were then incubated at 37 C in 5% CO2 for 48-96 hours for further downstream experiments.
Generation of CRISPR-Cas9 knockout cell lines Specific CRISPR guides were designed for DNA sequences within exon 1 (CGATCGAGCCTCGGTCAAGG) and exon 6 (AGAAGGG ATTGTTGCCAAAC) of the UBQLN4 gene using MIT web tool for CRISPR guide selection (http://zlab.bio/guide-design-resources).
The sequences for specific and non-targeting crRNA and trRNA were dissolved in 10 mM Tris-HCl, pH7.4. Thirty to fifty thousand cells of MDA-MB-231-Cas9 were plated and transfected using 50 nM of each crRNA and trRNA (GE Healthcare Dharmacon, CO, USA). After 48 hr the medium was changed and the cells were grown to confluence. Knockout was confirmed by immunoblotting.
Immunoblotting and chemical fractionation Cell lysates were obtained by lysing washed cells with RIPA buffer (50 mM Tris HCl pH 7.5, 150 mM NaCl, 1% NP40, 0.5% Sodium deoxycholate monohydrate, 0.1% SDS, 2.5 U Benzonase, 200 mM Mn 2+ ) containing protease inhibitor cocktail and incubated headover tail at 4 C for 60 min. Cell lysates were clarified by centrifugation and the protein concentration was quantified using the Bradford assay. Lysates were separated using SDS-PAGE and transferred onto nitrocellulose (0.2 mM) or PVFF membranes (0.45 mM). Membranes were blocked in 5% BSA-TBST. Membranes were reacted with primary antibodies, washed four times, 5 min each with 0.1% Tween-20 (pH 7.6), and subsequently incubated with peroxidase-conjugated secondary antibodies. Chemiluminescence was performed using Clarity Western ECL Substrate. For cellular fractionation experiments, U2-OS cells were chemically fractioned using a subcellular protein fractionation kit (Thermo Fisher Scientific, USA). For that, cells were harvested with trypsin-EDTA, centrifuged at 500g for 5 min and washed with ice-cold PBS. After adding CEB buffer to the cell pellet, the tube was incubated at 4 C for 10 min with gentle mixing. Following centrifugation at 500g for 5 min the supernatant (cytoplasmic extract) was transferred to clean pre-chilled tube on ice. Next, MEB buffer was added to the pellet, the tube briefly vortexed and incubated at 4 C for 10 min with gentle mixing. The tube was then centrifuged at 3000g for 5 min and the supernatant (membrane extract) transferred to a clean pre-chilled tube on ice. NEB buffer was added to the pellet, vortexed on the highest setting for 15 s. Following an incubation at 4 C for 30 min with gentle mixing, the tube was centrifuged at 5000g for 5 min and the supernatant (nuclear extract) transferred to a clean pre-chilled tube on ice. Lastly, room temperature NEB buffer containing Micrococcal Nuclease and CaCl 2 was added to the pellet, vortexed for 15 s and incubated at room temperature for 15 min. After incubation, the tube was centrifuged at 16,000g and the supernatant (chromatinbound nuclear extract) transferred to a clean pre-chilled tube on ice.
Cell viability measurement
Cell lines were plated into 96-well plates at densities of 5000-10000 cells/well. 24 hr later, cells were treated with various doses of genotoxic chemicals for 96 hr. After the incubation, room-temperature CellTiter-Gloâ Reagent (Promega, USA) was added 1:1 to each well and the plates were incubated at room temperature for 10 min. Luminescence was measured with the Tecan Infinite M1000 Pro (Tecan, Mä nnedorf, CHE) and normalized against control cells treated with vehicle solution.
Clonogenic survival assay U2-OS cells were plated in triplicate at densities of 100-3000 cells per 60 mm plate and incubated for 24 hr before exposure to various NCS doses. Two weeks later cell colonies were fixed and stained with 0.2% crystal violet in 50% ethanol and counted under a dissection microscope.
Cleaved caspase-3 measurement U2-OS cells were harvested and washed with 1 mL of ice-cold PBS. Fixation was performed by adding 1 mL of ice-cold 100% methanol slowly while gently vortexing. After 10 min, cells were washed three times with 1 mL of PBS + 0.5% BSA, and anti-cleaved caspase-3 (Asp175) was added. Cells were incubated for 2 hr at room-temperature, washed and incubated with secondary Alexa Fluor 488 in the dark for 1hr and washed three times with 1 mL of PBS + 0.5% BSA. Sorting was performed using a Beckman Coulter Gallios flow cytometer at 50.000 events/ sample and analyzed with the software Kaluza (Beckman Coulter).
Comet assay
Cells were treated with DNA damaging agents, harvested, and the comet procedure was applied using the CometAssay experimental system (Trevigen). For that, cells were mixed with low-melting agarose and the cell suspension was overlaid on microscope slides. Cell lysis was carried out within the agarose. After lysis, electrophoresis of the DNA trapped in the agarose was performed at 1 V/cm for 30 min. After staining the slides with SYBR Green dye for 10 min, images of 100 randomly selected cells per sample were captured using a Nikon eclipse 55i fluorescent microscope and digital fluorescent images were obtained by using the NIS-elements AR software. The relative length and intensity of DNA tails relative to heads is proportional to the amount of DNA damage in individual nuclei.
These parameters were measured observer-independent and in an unbiased fashion by tail moment quantification with TriTek Comet Score software (TriTek Corp., Sumerduck, VA). Exemplary images of single cells from comet slide samples were obtained post analysis.
DSB repair pathway assays U2-OS cells bearing a single-copy integration of the reporters DR-GFP (Gene conversion), or SSR (NHEJ:HR) were used to analyze the different DSB repair pathways (Ló pez-Saavedra et al., 2016) . In both cases, 4.000 cells were plated in 96-well plates. One day after seeding, cells were transfected with the indicated siRNA or infected with retroviral particles carrying the indicated plasmids.
The medium was changed after 6-8 hr. The following day, cells were infected with a lentivirus harboring I-SceI and labeled with BFP at a multiplicity-of-infection of 10 (Ló pez-Saavedra et al., 2016). After 24 hr, cells were washed with fresh medium and maintained during an additional 24 hr. Cells were then fixed with 4% paraformaldehyde, stained with Hoechst 33,432, and washed with PBS before visualization with a fluorescent microscope for blue, and in the case of SSR, green and red fluorescence. The repair frequency was calculated as the percentage of blue cells expressing GFP for the DR-GFP. For the NHEJ:HR balance, the ratio between green versus red cells in each condition was calculated. To facilitate the comparison between experiments, this ratio was normalized with siRNA or an empty vector control. Conditions that skewed the balance toward increased NHEJ repair resulted in a fold increase above 1. In contrast, a net decrease of this ratio (for example, values below 1) represented an imbalance of SSR toward HRR. Data represent a minimum of four sets of triplicate experiments. Statistical significance was determined using the paired sample t test.
Single Molecule Analysis of Resection Tracks
Single Molecule Analysis of Resection Tracks (SMART) was performed as previously described (Cruz-García et al., 2014) . For that purpose, U2-OS cells transfected with siRNA against UBQLN4, a control siRNA, UBQLN4.FLAG, UBQLN4.S318A.FLAG or empty-vector FLAG construct were cultured in the presence of 10mM bromodeoxyuridine (BrdU) for 24 hr, irradiated with 10 Gy of IR and harvested 1 hr later. Cells were embedded in low-melting agarose and in-gel DNA extraction followed. To stretch the DNA fibers, silanized coverslips were dipped into the DNA solution for 15 min and pulled out at constant speed (250mm/s). Coverslips were baked for 2 h at 60 C and incubated without denaturation with an anti-BrdU mouse monoclonal antibody. After washing with PBS, coverslips were incubated with a secondary antibody. The coverslips were mounted with ProLongâ Gold Antifade Reagent (Molecular Probes, Oregon, USA) and stored at À20 C. DNA fibers were observed using a Nikon NI-E microscope under a PLAN FLOUR40 3 /0.75 PHL DLL objective. The images were recorded and processed using NIS ELEMENTS Nikon software. For each experiment, at least 200 DNA fibers were analyzed, and the length of DNA fibers was measured using Adobe Photoshop CS4 Extended version 11.0 (Adobe Systems Incorporated). Experiments were repeated independently four times. Statistical significance in these experiments was determined with the paired Student's t test.
Laser microirradiation and imaging of cells U2-OS cells expressing ectopic, GFP-tagged proteins were plated on glass bottom dishes (MatTek, Ashland, MA) and pre-sensitized with 10 mM BrdU for 48 hr. The dishes were transferred into a microscope top-stage incubator equipped with a control system for gas mixture and humidity (Okolab, Ottaviani, Italy). DNA damage was induced on a Leica TCS SP8 confocal microscope (Leica Microsystems, Wetzlar, Germany) using a 405 nm diode laser focused through an HC PL APO 63X, 1.4-numerical aperture oil immersion objective (8% laser power, scan speed 650 msec, 40 scans). Images were acquired using the same system. Relocalization of endogenous proteins to sites of laser-induced DNA damage was followed by immunostaining. DNA damage was induced using two-photon-based micro-irradiation obtained from an 800 nm laser beam in an LSM 510 Meta confocal microscope (Carl Zeiss, Jena, Germany). The microscope was equipped with a Spectral-Physics Mai-Tai (Deep-See) multi-photon laser system focused through a 63 3 1.25 numerical aperture oil immersion objective. Microirradiation was carried out at 8% laser power and scan speed of 1.61 msec, with 40 repetitions at zoom 3 1. A Leica TCS SP8 confocal microscope was used for imaging. In order to visualize UBQLN4 and 53BP1 laser stripes, cells were washed with PBS and incubated for 3 min at room temperature with CSK buffer containing 10 mM PIPES, pH 7.0, 100 mM NaCl, 300 mM sucrose, 3 mM MgCl 2 , and 0.7% Triton X-100. The cells were then washed in PBS and incubated for another 3 min in CSK buffer supplemented with 0.3 mg/ml RNase A. The above described immunofluorescence protocol was then followed.
Immunostaining and fluorescence measurements HDFs were seeded onto 96 well plates for immunofluorescence assays. For RAD51 stainings, cells were additionally pre-extracted in sucrose buffer (25 mM HEPES pH 7.5, 50 mM NaCl, 1 mM EDTA, 3 mM MgCl 2 ,300 mM Sucrose, 0.5% Triton-X) for 2 min on ice. Cells were fixed for 10 minutes in room temperature with 4% Paraformaldehyde, followed by three washes with ice-cold 1x PBS. Subsequently, the cells were blocked for 60 min at room temperature in PBS containing 5% normal goat serum (NGS), 2% bovine serum albumin and 0.01% Triton X-100. Incubation with the primary antibody was performed over night at 4 C. Incubation with the secondary antibody was performed for 1 h at room temperature. Analysis was performed as described in ''High-content screening microscopy.'' In contrast, U2-OS cells were fixed and stained on regular coverslips. Cleaved caspase 3 intensity and nuclear foci of gH2AX in U2-OS cells were quantified using ImageJ software (with the PZfociEZ plugin for gH2AX nuclear foci).
High-content screening microscopy
High-content screening (HCS) microscopy was performed on HDFs using a Thermo Fisher Cellomics ArrayScan XTI with LED light source. Images of 1104 3 1104 pixels were acquired with a 20x objective (Zeiss) and analyzed using the Cellomics software package (Colocalization V.4 Bioapplication). Images were background corrected (3D surface fitting) and DAPI stained cell nuclei were identified according to the object selection parameters size: 100-1500 mm 2 , ratio of perimeter squared to 4p area: 1-2, length-to-width ratio: 1-5, average intensity: 400-4000, total intensity: 4 3 10 6 -2 3 10 7 . Foci of gH2AX, MRE11, RPA70, RAD51 and Ubiquitin intensities were quantified within the nuclear region at another excitation wavelength (485 ± 20 nm or 650 ± 20nm). Object selection parameters for foci were size: 0.1-10 mm 2 , ratio of perimeter squared to 4p area: 1-5, length-to-width ratio: 1-5, average intensity: 500-10000, total intensity: 300-2 3 10 6 . To determine the cell cycle stage, we analyzed the distribution of the total DAPI intensity using a custom R script. Four thresholds were adjusted manually to gate cells in 2N (G0/G1), 2-4N (S), and 4N (G2/M) stages, respectively. Cells in the G0/G1 phases possess a normal diploid DNA content (2N) whereas cells in G2/M contain exactly twice this amount (4N). As DNA is synthesized during S-phase, cells are found with a DNA content ranging between 2N and 4N. The gates were then applied to evaluate the mean number of foci in cells of the respective cell cycle stage. Single cell data were further processed and plotted using R packages. High content screening kinetic experiments were analyzed with R using ordinary two-way ANOVA. HCS microscopy results are means ± standard deviation; n = 3-4 wells; > 2000 cells/well; two-way ANOVA with Bonferroni's test. *p < 0.05; **p < 0.01; ***p < 0.001.
Immunoprecipitation
For GFP-Trap and FLAG-IP experiments, 293FT cells were transfected with respective plasmids, treated and harvested. Cells were then incubated in lysis buffer (150 mM NaCl, 50 mM Tris HCl pH 7.5, 2 mM MgCl 2 , 1% NP40 and EDTA-free protease inhibitor cocktail) for 60 min with rotation at 4 C. For the identification of ubiquitin-dependencies 10 mM N-Ethylmaleimide (NEM) was added to the lysis buffer. The resultant cell lysates were pre-cleared at 15.000 g at 4 C for 20 min. Lysates were incubated with GFP-Trap agarose beads or FLAG-M2 agarose beads at 4 C for 3 hr. The resulting complexes were washed with wash buffer (150 mM NaCl, 50 mM Tris HCl pH 7.5, 0.5% NP40 and complete protease inhibitor cocktail) and analyzed by SDS-PAGE. In the case of HIS immunoprecipitations, Ni-NTA magnetic beads were added to lysates also containing 15 mM Imidazole, 5 mMTris-(2-carboxyethyl)-phosphin (TCEP) and incubated overnight at 4 C with gentle agitation. Beads were washed 5 times with IP wash buffer (20 mM HEPES pH 7.9, 300 mM NaCl, 10% Glycerol, 0.1% NP-40, 5mM TCEP, 15 mM Imidazole, 10mM NEM) and eluted in elution buffer (20 mM HEPES pH 7.9, 300 mM NaCl, 10% Glycerol, 0.1% NP-40, 5 mM TCEP, 200 mM Imidazole). In the case of USP2 treatment, 20 ml USP2 buffer (35 mM HEPES pH 7.9, 75 mM NaCl, 1 mM DTT) and 50 mM USP2 were added to the sample and the sample was incubated for 30 min at 37 C with gentle agitation.
LC-MS/MS phosphorylation analysis
Cell lysates were precipitated with acetone and resuspended in 8 M Urea. After reduction with DTT and carbamidomethylation with IAA, proteins were digested overnight at 37 C, using the proteases LysC (Wako) and, after dilution with 50 mM potassium phosphate buffer pH 5.8, trypsin (Promega) and GluC (Promega). Samples were desalted using SepPak C18 cartridges (Waters) and phosphorylated peptides enriched with the High-Select TiO2 Phosphopeptide Enrichment Kit (Thermo Fisher). Proteomic analysis was performed using an Easy nLC 1200 UHPLC coupled to a QExactive HF-X mass spectrometer (Thermo Fisher). Peptides were resuspended in Solvent A (0.1% FA), picked up with an autosampler and loaded onto in-house made 50 cm fused silica columns (internal diameter (I.D.) 75 mm, C18 1.7 mm, Dr. Maisch beads) at a flow rate of 1.5 mL/min. A 90 min segmented gradient of 4%-55% Solvent B (80% ACN in 0.1% FA) over 81 min and 55%-95% Solvent B over 9 min at a flow rate of 250 nL/min was used to elute peptides. Eluted peptides were sprayed into the heated transfer capillary of the mass spectrometer using a nano-electrospray ion source (Thermo Fisher Scientific). The mass spectrometer was operated in a data-dependent mode, where the Orbitrap acquired full MS scans (350-1650 m/z) at a resolution (R) of 60,000 with an automated gain control (AGC) target of 3 3 10 6 ions collected within 20 ms. The dynamic exclusion time was set to 20 s. From the full MS scan, the 15 most intense peaks (z R 2) were fragmented in the high-energy collision-induced dissociation (HCD) cell. The HCD normalized collision energy was set to 28%. LC-MS/MS scans with an ion target of 1.5 3 10 5 ions were acquired with R = 30,000, with a maximal injection time of 54 ms and an isolation width of 1.3 m/z. The raw files were processed using MaxQuant software (version 1.5.3.8) and its implemented viewer and Andromeda search engine (Cox et al., 2011) . Parameters were set to default values and Phospho (STY) was added as variable modification. Intensities were scaled to mean of zero and unit variance for separate measurements. Graphs were generated and two-sided t test.
Histological analysis
Formalin-fixed paraffin-embedded (FFPE) nevus and melanoma samples were cut into 4mm thick sections and mounted on slides. After UBQLN4 staining, samples were assessed and the H-score calculated.
Measurement of C. elegans HRR efficiency
Worms were synchronized at late L4 stage by picking and were kept for 24 hr at 20 C until reaching adulthood. For each condition, 5 adult worms were transferred to 35-mm NGM plates seeded with a drop of OP50 and allowed to lay eggs for a time period of 2 hr at 20 C. Animals were then removed from plates and eggs were immediately irradiated with 0, 20 or 40 Gy of g-irradiation. 24 hr later, numbers of hatched and non-hatched eggs were counted and percentages of embryonic survival were calculated. Each experiment was performed in biological triplicates.
C. elegans immunofluorescence staining Wt and ubql-1(tm1574) mutants were synchronized at L4 larval stage by picking and kept at 20 C. 24 hr later worms were either exposed to 90 Gy of g-irradiation using a BIOBEAM 8000 with Cs137 radionucleotide source, or were left untreated to serve as negative controls. Worms were kept another 24 hr at 20 C before being dissected with syringe needles to expose germlines. Tissues were fixed for 5 min with 4% paraformaldehyde solution on adhesive HistoBond â + slides (Paul Marienfeld GmbH & Co. KG) before freeze cracking on dry ice. Slides were subsequently fixed for 1 min in ice-cold methanol at À20 C and washed 3x in PBS-T followed by a 30 min blocking step with 10% donkey serum in PBS-T. For detection of ubiquitinylated conjugates tissues were incubated overnight at 4 C with monoclonal FK2 antibody (Merck Millipore; Dilution: 1:500 in 10% donkey serum in PBS-T). The next day, slides were washed 3x in PBS-T and exposed to secondary antibody (AlexaFluor 488 Donkey anti-Mouse IgG; Dilution: 1:500 in 10% donkey serum in PBS-T) for 2 hr at room-temperature in the dark. After 3 final washes in PBS-T, slides were mounted with a drop of DAPI Fluoromount-G â (SouthernBiotech) and sealed with nailpolish. Images of five individual germlines per condition were taken using a Zeiss Meta 710 confocal microsope. Images were subsequently processed and analyzed using the ImageJ software package.
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using the GraphPad Prism software package. The type of statistical analyses, parameters and number of replicates are indicated for each experiment in the figure legends. For all tests, p value significance was defined as follows: not significant (n.s.) p > 0.05; *p < 0.05; **p < 0.01; ***p < 0.001.
DATA AND SOFTWARE AVAILABILITY
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD011488. High-content screening (HCS) microscopy raw data has been deposited to the Mendeley repository under https://doi.org/10.17632/gz4xvwbvhs.1. , 2018) . Human Tert-immortalized fibroblasts seeded in 384-microwell plates were reverse-transfected with siRNAs representing 1591 siRNA pools targeting mRNAs of various proteins that are involved in protein ubiquitylation and the ubiquitin-proteasome system. 72hrs later, cells were treated with 100 ng/ml NCS, and 24 hr later fixed and stained with an antibody against phospho-KAP-1. (D) Immunoblot to demonstrate the detection of S318 UBQLN4 phosphorylation in U2-OS cells using a specific anti-phospho S318 antibody. GFP-tagged UBQLN4 in wt and S318A mutant versions was ectopically expressed in U2-OS cells. At 1 hr after treatment with 10 Gy of IR, ectopic UBQLN4 was immunoprecipitated using an anti-GFP antibody, and the immune complexes were blotted with the indicated antibodies. I = Input; UB = Unbound fraction; IP: Bound fraction. A low-intensity unspecific phosphorylation band is seen in the S318A mutant control IP fraction. (E) Densitometry analysis of three independent experiments related to (D). Densitometry was quantified by ImageJ of S318-UBQLN4 phosphorylation and normalized to wt UBQLN4. Error bars display the standard deviation of three independent experiments. UT = untreated; T = treated. p values were calculated using the t test with Welch's correction. p < 0.05 (*). (F) Immunoblot to demonstrate dimerization/polymerization of tagged UBQLN4. GFP-tagged and FLAG-tagged UBQLN4 was ectopically expressed in U2-OS cells, ectopic UBQLN4 was immunoprecipitated using FLAG beads and the immune complexes were blotted with UBQLN4 antibody. Empty-vector GFP served as a control. (G) U2-OS cells transfected with the indicated shRNAs, treated with 10 Gy of IR, and processed for immunoblotting with anti-UBQLN4-and anti-pS318 UBQLN4 antibody at the indicated time points. (H) Cellular extracts of U2-OS cells were subjected to immunoblotting after treatment with etoposide (Eto), camptothecin (CPT) or hydroxyurea (HU) at the indicated time points. pS824-KAP1 antibody was used as a positive control. (I) Densitometry analysis of four independent experiments related to (H) . Densitometry was quantified by ImageJ of S318-UBQLN4 phosphorylation and normalized to wt UBQLN4. Error bars display the standard deviation of four independent experiments. p values were calculated using the t test with Welch's correction. p < 0.05 (*);p < 0.01 (**). (J) U2-OS cells were fractionated (Cyt = cytoplasma; Nuc = nuclear; Chr = chromatin; Mem = membrane) following 1 hr of 500 ng/ml NCS and subjected to immunoblotting. Anti-Histone H3 antibody served as control for the chromatin fraction. (K) Densitometry analysis of three independent experiments underlying Figure 3E . Densitometry was quantified by ImageJ of S318-UBQLN4 phosphorylation and normalized to wt UBQLN4. Error bars display the standard deviation of three independent experiments. p values were calculated using the t test with Welch's correction. p < 0.05 (*); p < 0.01 (**). (L) Selected LC-MS/MS scan of the UBQLN4 peptide with phosphorylated S144 and annotated b-and y-ions. Fragment ions marked with an asterisk (*) result from loss of the phospho-group. Inset top right: LC-MS/MS measured intensities of the phosphorylated S144 site after indicated treatments. (M) Immunoblot depicting the expression levels of endogenous and ectopic UBQLN4 in cells used for clonogenic survival assays in Figure 3G . (N) Immunoblot depicting the expression levels of endogenous and ectopic UBQLN4 in cells used for clonogenic survival assays in (O) . (O) Clonogenic survival curve of U2-OS cells transduced with shRNA directed against UBQLN4 (targeting 3 0 UTR) and mutant forms of UBQLN4 and subsequently treated with various NCS doses. Error bars represent the standard deviation of the mean of n = 3 experiments. p values were calculated using the t test with Welch's correction not assuming equal variance. p < 0.05 (*). (P) Immunoblot displaying the expression level of UBQLN4 of cell lines used in Figure 3H . (Q) Representative images of neutral comet assays of NCS-induced (50 ng/ml) DSBs in U2-OS cells transduced with either shControl or shUBQLN4 and complemented with UBQLN4-wt, S318A mutant or S318D mutant plasmid related to Figure 3H . Scale bar, 10 mm. (legend continued on next page)
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